iShares MSCI Total International Index Fund Investor A Shares (BDOAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
11.10
0.00 (0.00%)
May 30, 2025, 8:59 AM EDT
11.11% (1Y)
Fund Assets | 1.74B |
Expense Ratio | 0.41% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 0.27 |
Dividend Yield | 2.47% |
Dividend Growth | 10.06% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 31, 2025 |
Previous Close | 11.10 |
YTD Return | 14.28% |
1-Year Return | 14.13% |
5-Year Return | 59.14% |
52-Week Low | 9.23 |
52-Week High | 11.15 |
Beta (5Y) | 1.04 |
Holdings | 1909 |
Inception Date | Jun 30, 2011 |
About BDOAX
The fund is a "feeder" fund that invests all of its assets in the master portfolio. It will be substantially invested in equity securities in the MSCI ACWI ex USA Index, and will invest, under normal circumstances, at least 80% of its net assets in securities or other financial instruments that are components of or have economic characteristics similar to the securities included in the MSCI ACWI ex USA Index.
Category Foreign Large Blend
Stock Exchange NASDAQ
Ticker Symbol BDOAX
Index MSCI AC World ex USA NR USD
Performance
BDOAX had a total return of 14.13% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.21%.
Top 10 Holdings
11.36% of assetsName | Symbol | Weight |
---|---|---|
Taiwan Semiconductor Manufacturing Company Limited | 2330 | 2.50% |
Tencent Holdings Limited | 0700 | 1.54% |
SAP SE | SAP | 1.03% |
Nestlé S.A. | NESN | 0.99% |
Alibaba Group Holding Limited | 9988 | 0.99% |
ASML Holding N.V. | ASML | 0.96% |
Roche Holding AG | ROG | 0.86% |
AstraZeneca PLC | AZN | 0.84% |
Shell plc | SHEL | 0.82% |
Novo Nordisk A/S | NOVO.B | 0.82% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 31, 2025 | $0.08186 | Apr 1, 2025 |
Dec 12, 2024 | $0.02401 | Dec 13, 2024 |
Sep 30, 2024 | $0.06322 | Oct 1, 2024 |
Jun 28, 2024 | $0.10535 | Jul 1, 2024 |
Mar 28, 2024 | $0.06365 | Apr 1, 2024 |
Dec 14, 2023 | $0.04521 | Dec 15, 2023 |